Viperin controls chikungunya virus-specific pathogenic T cell IFN? Th1 stimulation in mice

Viperin controls chikungunya virus-specific pathogenic T cell IFN? Th1 stimulation in mice

10.26508/lsa.201900298

Saved in:

Bibliographic Details
Main Authors:	Carissimo, G., Teo, T.-H., Chan, Y.-H., Lee, C.Y.-P., Lee, B., Torres-Ruesta, A., Tan, J.J.L., Chua, T.-K., Fong, S.-W., Lum, F.-M., Ng, L.F.P.
Other Authors:	MEDICINE
Format:	Article
Published:	Rockefeller University Press 2021
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/210012
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Plasmodium co-infection protects against chikungunya virus-induced pathologies
by: Teo, T.-H, et al.
Published: (2020)

Co-infection with Chikungunya virus alters trafficking of pathogenic CD8+ T cells into the brain and prevents Plasmodium-induced neuropathology
by: Teo, T.-H, et al.
Published: (2020)

Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate
by: Chan, Y.-H., et al.
Published: (2021)

The IFN response in bats displays distinctive ifn-stimulated gene expression kinetics with atypical RNASEL induction
by: De La Cruz-Rivera, P.C, et al.
Published: (2020)

Structural and binding characterization of the antiviral host Proteins, VIPERIN and VAPC
by: SHAVETA GOYAL
Published: (2012)

Chikungunya: a bending reality
by: Her, Z., et al.
Published: (2015)

Adenovirus vectored IFN-alpha protects mice from lethal challenge of Chikungunya virus infection
by: Chen, Huixin, et al.
Published: (2021)

Structural characterization reveals that viperin is a radical S-adenosyl-l-methionine (SAM) enzyme
by: Shaveta, G., et al.
Published: (2011)

VCP/p97 is a proviral host factor for replication of chikungunya virus and other alphaviruses
by: Carissimo, G., et al.
Published: (2022)

Immuno-biology of Chikungunya and implications for disease intervention
by: Kam, Y.-W., et al.
Published: (2015)

Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity
by: Poh, C.M., et al.
Published: (2021)

Antibody-mediated enhancement aggravates chikungunya virus infection and disease severity
by: Lum, F.-M, et al.
Published: (2020)

Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection
by: Roques, P, et al.
Published: (2020)

Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genes
by: Tian, J, et al.
Published: (2020)

HLA class I restriction as a possible driving force for Chikungunya evolution
by: Tong, J.C., et al.
Published: (2011)

Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency
by: Warter, L., et al.
Published: (2016)

IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
by: Ng L.F.P., et al.
Published: (2018)

Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population
by: Ang L.W., et al.
Published: (2020)

IFN-γ mediates the rejection of haematopoietic stem cells in IFN-γR1-deficient hosts
by: Rottman M., et al.
Published: (2020)

Chikungunya virus neutralization antigens and direct cell-to-cell transmission are revealed by human antibody-escape mutants
by: Lee C.Y., et al.
Published: (2019)

IRF-7 Mediates Type I IFN Responses in Endotoxin-Challenged Mice
by: Sin, W.-X., et al.
Published: (2021)

Early clearance of Chikungunya virus in children is associated with a strong innate immune response
by: Simarmata, D, et al.
Published: (2020)

Type i interferon shapes the quantity and quality of the anti-zika virus antibody response
by: Yi-Pin Lee, C., et al.
Published: (2021)

Unique epitopes recognized by antibodies induced in chikungunya virus-infected non-human primates: Implications for the study of immunopathology and vaccine development
by: Kam Y.-W., et al.
Published: (2020)

Entomologic and virologic investigation of chikungunya, Singapore
by: Ng, L.-C, et al.
Published: (2020)

Chikungunya outbreak, Singapore, 2008
by: Leo, Y.S, et al.
Published: (2020)

An Integrated Lab-on-Chip for Rapid Identification and Simultaneous Differentiation of Tropical Pathogens
by: Tan J.J.L., et al.
Published: (2019)

Sero-Prevalence and Cross-Reactivity of Chikungunya Virus Specific Anti-E2EP3 Antibodies in Arbovirus-Infected Patients
by: Kam Y.-W., et al.
Published: (2020)

HOST ADAPTIVE IMMUNITY MODULATES CHIKUNGUNYA DISEASE MANIFESTATION
by: LUM FOK MOON
Published: (2015)

Chikungunya mimicking atypical kawasaki disease in an infant
by: Lee, Y.S., et al.
Published: (2011)

VCP/p97 is a proviral host factor for replication of chikungunya virus and other alphaviruses
by: Carissimo, Guillaume, et al.
Published: (2020)

Suramin inhibits chikungunya virus entry and transmission
by: Ho Y.-J., et al.
Published: (2019)

The CXC chemokines gamma interferon (IFN-γ)-inducible protein 10 and monokine induced by IFN-γ are released during severe melioidosis
by: Fanny N. Lauw, et al.
Published: (2018)

Mosquito Cellular Factors and Functions in Mediating the Infectious entry of Chikungunya Virus
by: Lee R.C.H., et al.
Published: (2018)

The risk of chikungunya fever in a dengue-endemic area
by: Massad, E., et al.
Published: (2011)

A DNA vaccine against Chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates
by: Mallilankaraman K., et al.
Published: (2018)

Atypical chikungunya virus infections in immunocompromised patients
by: Kee, A.C.L., et al.
Published: (2011)

Refractoriness of Aedes aegypti (linnaeus) to dual infection with dengue and chikungunya virus
by: A. Rohani, et al.
Published: (2018)

Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection
by: Chan, Y.-H., et al.
Published: (2021)

Infectious viral quantification of chikungunya virus—virus plaque assay
by: Kaur, P, et al.
Published: (2020)